Thermo Fisher Scientific Inc., a global leader in scientific solutions, announced in a press release that they have secured a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ Imaging Institute) (1). This partnership is designed to help spur advancements in cryo-electron microscopy (cryo-EM) technology, enhancing researchers' ability to visualize human cells at unprecedented resolution (1). The long-term goal of this partnership is to lead to new therapeutic developments and scientific discoveries (1).
At its core, cryo-Em is an advanced imaging technique (2). Scientists use this technique in order to better understand biological molecules (2). Because of the technique’s core focus, scientists often use cryo-EM technology in disease research and drug development, and it also plays a role in developing new vaccines (1,2). Currently, although cryo-EM technology has improved, limitations still remain. For example, researchers recognize the need for improved imaging contrast and resolution (1).
This partnership between Thermo Fisher Scientific and the CZ Imaging Institute will focus on advancing laser phase plate technology to refine the capabilities of cryo-EM technology, which will allow scientists to explore the inner workings of human cells in three dimensions at nanoscale resolution (1).
A key aspect of this effort builds on previous work with Professor Holger Müller and his team at the University of California, Berkeley, and Lawrence Berkeley National Laboratory (Berkeley Lab). The collaboration, which has already led to the invention and ongoing development of the continuous laser phase plate for electron microscopy, will now be expanded with Thermo Fisher and the CZ Imaging Institute working together to further refine the technology (1). By enhancing imaging precision, this partnership will enable breakthroughs in biological research and medical science (1).
“Broadening our understanding of basic cellular biology has the potential to unlock new layers of scientific research and therapeutic development,” Trisha Rice, vice president and general manager of life sciences for Thermo Fisher’s electron microscopy business, said in a press release (1). “We are excited to collaborate with the CZ Imaging Institute to create new approaches in analytical science that aid future discovery.”
This initiative aligns with the broader mission of the Chan Zuckerberg Initiative (CZI) to tackle major scientific challenges. A central goal of CZI is to develop advanced imaging systems that provide extraordinary insights into human biology (1). By leveraging the expertise of scientists and cryo-EM specialists from both organizations, the partnership will maximize the impact of laser phase plate technology, allowing researchers worldwide to gather more comprehensive data and advance cutting-edge biological research (1).
Matthias Haury, acting executive director and chief operating officer of the CZ Imaging Institute, highlighted the collaboration’s significance.
“At the Imaging Institute, we’re focused on innovating breakthrough imaging technologies to enable scientists to see and measure what is currently invisible within our cells and gain deeper insights into the biological mechanisms of human health and disease,” Haury said in a press release (1). “We want to advance not only the experimental side of imaging science but also deliver solutions to the community. Technology alliances with industry partners like Thermo Fisher allow us to accelerate and scale technology development and share these advances with scientists worldwide more rapidly.”
The CZ Imaging Institute actively works on developing imaging hardware and software tools to create multimodal biological imaging systems that enhance scientific understanding (1). Thermo Fisher Scientific Inc.’s mission is to support customers in making the world healthier, cleaner, and safer by accelerating life sciences research, addressing complex analytical challenges, increasing laboratory productivity, or advancing patient care through diagnostics and therapeutics (1).
With this partnership, Thermo Fisher Scientific and the CZ Imaging Institute will have an opportunity to align both organization’s goals with the broader mission of advancing scientific discovery.
